Metformin Effects on Lipid Accumulation and Cell Proliferation in Hepatocellular Carcinoma

A research dataset from figshare, authored by Yannan Qi and last updated on 2026-05-03, investigating the anticancer mechanisms of metformin in hepatocellular carcinoma. The dataset, 10.6 MB in size, includes DOCX and PPTX files detailing how metformin regulates METTL3-mediated m6A methylation to counteract lipid accumulation and cell proliferation in HepG2 and Huh7 cell lines.

Use Cases

• Analyzing the relationship between metformin treatment and lipid droplet accumulation in HCC cells based on the described experimental findings.
• Investigating the regulatory role of METTL3 and FTO in m6A RNA methylation under metformin exposure as described in the mechanistic study.
• Modeling the METTL3/ACC1/FASN signaling axis as a downstream pathway affected by metformin, based on the transcript-level analyses mentioned.
• Studying the anti-proliferative effects of metformin on HepG2 and Huh7 cell lines as described in the functional assays.

Strengths

• Dataset is licensed under CC-BY-4.0, allowing for broad reuse and redistribution.
• The description provides a detailed mechanistic explanation of metformin's action in HCC, including specific cell lines (HepG2, Huh7) and molecular targets (METTL3, FTO, ACC1, FASN).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset consists of DOCX and PPTX files, which may require specific software for access and are not inherently machine-readable as structured data.

Provenance

Source

figshare

Collection Method

Likely contains experimental results and analyses from a biological study.

Time Range

null

Freshness

Last updated 2026-05 13:00:04; freshness should be verified.

Geography

null